Journal of Virology Research & Reports最新文献

筛选
英文 中文
“Against all Odds”-Increasing Demand and Uptake of Immunization Services Among Non-Fully Immunized Children in Northern Nigeria Using a Positive Deviance Approach: Implementation Science Research “排除万难”-在尼日利亚北部未充分接种疫苗的儿童中使用积极偏差方法增加免疫服务的需求和吸收:实施科学研究
Journal of Virology Research & Reports Pub Date : 2023-03-31 DOI: 10.47363/jvrr/2023(4)150
Obioma Azurunwa, Olakunle Yusuf
{"title":"“Against all Odds”-Increasing Demand and Uptake of Immunization Services Among Non-Fully Immunized Children in Northern Nigeria Using a Positive Deviance Approach: Implementation Science Research","authors":"Obioma Azurunwa, Olakunle Yusuf","doi":"10.47363/jvrr/2023(4)150","DOIUrl":"https://doi.org/10.47363/jvrr/2023(4)150","url":null,"abstract":"Introduction: Children still die from vaccine-preventable diseases. Nigeria contributes 30% of unimmunized children <5 years globally. This study was conducted in 4 Local Government Areas (LGA) in Niger and Gombe States employing the positive deviance (PD) approach to increase vaccination demand in low child immunization coverage settings. Methodology: The was a quasi-experimental study, conducted between December 2019 and April 2021, comparing pre- and post- intervention vaccination uptake after 5 months of intervention among 400 caregivers of non-fully immunized children (CNFIC). We trained 40 caregivers of fully immunized children (CFIC) as mentors using a participatory learning and action tool. The CNFIC were matched in ratio 10:1 with CFIC and exposed to 8 impact meetings and 10 home-visits using communication materials to increase vaccination knowledge. Paired T-test and adjusted odd ratios from logistic regression models were used to determine change in immunization uptake and factors associated with full immunization for age, respectively. Result: A total of 343 CNFIC were successfully followed up during intervention. The age range of children in the study was 2 to 12 months with the female (178) slightly more than the male (165). The mean vaccine uptake rate increased from 43.7% to 85.9% (T= -29.3, P<0.005) with 55.4% fully vaccinated for age post-intervention. Safer LGA residence, being a housewife caregiver, and younger caregivers <30 years were positive determinants of full vaccination. Conclusion: Adopting the PD approach to low uptake vaccination settings can increase vaccination demand and coverage. This approach can be leveraged in other public health challenges.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121627016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation of Nitric Oxide Releasing Solution and Assessment of in Vitro Efficacy on Sars-Cov-2 Virus Using Plaque Assay 一氧化氮释放液的制备及空斑法体外对Sars-Cov-2病毒的药效评价
Journal of Virology Research &amp; Reports Pub Date : 2023-03-30 DOI: 10.47363/jvrr/2023(4)148
M. Desai
{"title":"Preparation of Nitric Oxide Releasing Solution and Assessment of in Vitro Efficacy on Sars-Cov-2 Virus Using Plaque Assay","authors":"M. Desai","doi":"10.47363/jvrr/2023(4)148","DOIUrl":"https://doi.org/10.47363/jvrr/2023(4)148","url":null,"abstract":"In our present research, a method for preparing acidified nitrite solution comprising of biocompatible liquids which is able to release an active ingredient Nitric oxide (NO) gas at a pH scope of 3-4 is revealed. By performing an In-Vitro viral plaque assays, the cytopathic effect of NO on respiratory virus such as SARS-CoV-2 was determined. We discovered that the number of plaques reduced in a dose dependent manner as viral entities were found sensitive towards NO gas. Hence, we assert that our NO releasing acidified nitrite solution is relevant as it has shown a cytopathic effect and inhibited the replication of respiratory viruses like SARS-CoV-2 and other rhinovirus spp. Besides, a convenient and portable delivery system has been provided for administration of NO gas instead of cylinder-based system.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124639317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Who’s the Opportunist? CMV Pneumonia in HIV-Infection-Case Report 谁是机会主义者?hiv感染中的巨细胞病毒性肺炎病例报告
Journal of Virology Research &amp; Reports Pub Date : 2022-12-31 DOI: 10.47363/jvrr/2022(4)145
Joana Lopes Ferreira
{"title":"Who’s the Opportunist? CMV Pneumonia in HIV-Infection-Case Report","authors":"Joana Lopes Ferreira","doi":"10.47363/jvrr/2022(4)145","DOIUrl":"https://doi.org/10.47363/jvrr/2022(4)145","url":null,"abstract":"Cytomegalovirus (CMV) pneumonia is a viral infection of the lungs that affects immunocompromised patients. Although it is a rare opportunistic infection in the setting of HIV (Human Immunodeficiency Virus)-infection, in most of these patients, CMV pneumonia is believed to be caused by reactivation secondary to severe immunocompromise.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124507688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti Phytoviral Activities of Gunapaselam, On Tobacco Necrotic Virus (Tnv) Affecting Cyamopsis Tetragonoloba L (Taub) Gunapaselam抗烟草坏死病毒(Tnv)的活性研究
Journal of Virology Research &amp; Reports Pub Date : 2022-10-31 DOI: 10.47363/jvrr/2022(4)147
Poonam Sethi
{"title":"Anti Phytoviral Activities of Gunapaselam, On Tobacco Necrotic Virus (Tnv) Affecting Cyamopsis Tetragonoloba L (Taub)","authors":"Poonam Sethi","doi":"10.47363/jvrr/2022(4)147","DOIUrl":"https://doi.org/10.47363/jvrr/2022(4)147","url":null,"abstract":"Tobacco Necrotic Virus (TNV) is a plant disease affecting most of the legumes and other vegetable crops. The primary symptom being abnormal coloring or necrotic tissue in the leaves. Currently only chemical control of the virus is possible. There are, however, cultural management options to reduce the risk of the virus. The ‘ABC’ of TNV is (A) refers to dark brown raised patches, (B) dark sunken lesions (C) light brown cracked patches. Gunapaselam is a plant tonic made with fish extracts along with jaggery .Serial dilutions of the Fish Tonic ranging from1, 10,100 to 1000µl were applied to the host plant Cyamopsis tetragonoloba (Cluster Bean).The promising levels being 100 µl.Gunapaselam was applied as a liquid foliar spray.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114454668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Pregnant Women with Sars-Cov2 Infection in the 3rd Trimester of Pregnancy 妊娠晚期Sars-Cov2感染孕妇的临床特征
Journal of Virology Research &amp; Reports Pub Date : 2022-08-30 DOI: 10.47363/jvrr/2022(3)146
L. C.
{"title":"Clinical Characteristics of Pregnant Women with Sars-Cov2 Infection in the 3rd Trimester of Pregnancy","authors":"L. C.","doi":"10.47363/jvrr/2022(3)146","DOIUrl":"https://doi.org/10.47363/jvrr/2022(3)146","url":null,"abstract":"Objectives: The aim of our study is to present the cclinical characteristics of pregnant women with SARS-COV2 infection in the 3rd trimester of pregnancy. Methods: We retrospectively reviewed the medical records of all pregnant women from March to December 2020 in Infanta Leonor University Hospital, in Madrid. Infected women during the 3rd trimester of pregnancy or at delivery time with SARS-CoV2 diagnosis composed infected group, and non-infected women with SARS-CoV2 composed non-infected group. The infection status was determined via RT-PCR of nasopharyngeal swab specimen. Women in our study were not vaccinated because in the first and second waves of the epidemic the indication for vaccination in pregnant women was not clear. Results: 1262 non-infected pregnant women and 86 SARS-CoV2 positive pregnant women were admitted to our clinic during the study period. Within the group of infected pregnant women, they were 49 cases (56.98 %) symptomatic and 37 cases (43.02 %) asymptomatic. In the group of symptomatic infected women, the majority were mild cases (80.23 %). In the group of uninfected pregnant women, the main complication was gestational diabetes 14 (1.09 %) We did not find any complications during pregnancy in case group. Cesarean section was performed in 16.67 % of the infected pregnant women and in 21.71 % of the control group. Mean neonatal birth weight was 3.240 g in case group and 3.210 g in non-infected group. Neonatal admission to NICU was 9.52 % in cases while in the control group was 1.19 % being the most frequent reason for admission due to respiratory distress syndrome. Conclusion: SARS-CoV2 infection in pregnant women in the third trimester does not worsen the prognosis of pregnancy in our study, although metaanalyses suggest heightened risk of COVID-19 severity and adverse pregnancy and perinatal outcomes among women with certain demographic and health profiles.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129170808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sars-Cov-2 and COVID-19: Epidemiological, Diagnostic, and Therapeutic Aspects in Pointe-Noire, Republic of the Congo Sars-Cov-2和COVID-19:刚果共和国黑角的流行病学、诊断和治疗方面
Journal of Virology Research &amp; Reports Pub Date : 2022-06-30 DOI: 10.47363/jvrr/2022(3)144
Luc Magloire Anicet Boumba
{"title":"Sars-Cov-2 and COVID-19: Epidemiological, Diagnostic, and Therapeutic Aspects in Pointe-Noire, Republic of the Congo","authors":"Luc Magloire Anicet Boumba","doi":"10.47363/jvrr/2022(3)144","DOIUrl":"https://doi.org/10.47363/jvrr/2022(3)144","url":null,"abstract":"Introduction: The novel coronavirus also called SARS-COV-2 was declared a global pandemic by the WHO in March 2020. In the Republic of Congo, the first imported case was introduced on March 14, 2020. Pointe-Noire, whose 1st case was reported on March 17, 2020, is described as the second epicenter of the disease after Brazzaville the capital. Objective: In this work, the authors described the epidemiological, diagnostic and therapeutic aspects that contributed to the management of COVID-19 patients in Pointe-Noire. Material and Method: This was a cross-sectional descriptive study. The situational analysis was based on the situation report (SITREP) n°: 434 including COVID-19 data from the department of Pointe-Noire since the declaration of the first case until June 19, 2021, a period of 15 months. The biological diagnosis was exclusively based on RT-PCR from a nasopharyngeal swab. The extraction was carried out using two processes: filter column extraction and magnetic ball extraction using different kits. Amplification was performed on five types of PCR instruments.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"127 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114860436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superiorly Broad Natural Immunity to Covid Infection Can Potentially Provide Longer Lasting Protection against Immune Evasion by Emerging Variants from Alpha to Omicron and Possibly Beyond to Omega 对新冠病毒感染的超强广泛天然免疫力可能会提供更持久的保护,抵御从α到欧米克隆,甚至可能超越到欧米伽的新变体的免疫逃避
Journal of Virology Research &amp; Reports Pub Date : 2022-04-30 DOI: 10.47363/jvrr/2022(3)142
Girish J. Kotwal
{"title":"Superiorly Broad Natural Immunity to Covid Infection Can Potentially Provide Longer Lasting Protection against Immune Evasion by Emerging Variants from Alpha to Omicron and Possibly Beyond to Omega","authors":"Girish J. Kotwal","doi":"10.47363/jvrr/2022(3)142","DOIUrl":"https://doi.org/10.47363/jvrr/2022(3)142","url":null,"abstract":"COVID has become one of the deadliest obligate intracellular pathogens in over 100 years. COVID pandemic’s devastation causing to date 6.05+ million global deaths from over 460 million confirmed positive infections globally in just 2 years and close to 964,000+ US deaths out of 79.5 million confirmed positive cases in the US, continues with no sign of eradication of the virus. Antigenic variation is a predominant way of microorganisms causing human diseases to evade innate and acquired immunity. A major reason for that is COVID’s ability to evade human innate and acquired immune defenses by antigenic variation and to breach the weaker immune defenses of those among us who could not mount a timely and effective immune response to sustain ferocious attack on lungs and survive with great difficulty or succumb to an inability to breathe. While it is globally observed by Physician scientists that the OMICRON variant is highly transmissible but causes only MILD symptoms, because it is present only in the upper respiratory tract. A more virulent variant having a similar ability to spread fast could be catastrophic. How can immune evasion by COVID and its emerging variants be circumvented with better vaccines and treatments? It is high time to develop second generation of vaccines with broader protection that more closely simulates natural infection and viral entry inhibitors, eg. enveloped virus neutralizing compounds (EVNCs) that have proven broad spectrum neutralization of pandemic Influenza viruses like H5N1 or SARS-CoV-1, could prove effective against emerged and rapidly emerging strains of COVID like Omicron. A lab. Report a year after prior severe COVID infections but without any vaccine or booster dose clearly suggests that natural immunity acquired during infection is long lasting and should be meaningfully recognized by CDC and other agencies as, at least equivalent by immunization with vaccines against the emerging variants mutating periodically due to genetic variation and viral evasion.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127092499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Analysis of Vaccine Research, Development, and Distribution with Specific Focus on Covid-19 Vaccine Information and Development 以Covid-19疫苗信息与开发为重点的疫苗研发与分布分析
Journal of Virology Research &amp; Reports Pub Date : 2022-04-30 DOI: 10.47363/jvrr/2022(3)143
Emma Kathleen Moore
{"title":"An Analysis of Vaccine Research, Development, and Distribution with Specific Focus on Covid-19 Vaccine Information and Development","authors":"Emma Kathleen Moore","doi":"10.47363/jvrr/2022(3)143","DOIUrl":"https://doi.org/10.47363/jvrr/2022(3)143","url":null,"abstract":"Given the immediate circumstances of the looming Covid-19 pandemic, now more than ever it is important for vaccinations to be given and received. Far from the celebration that a vaccine for this deadly disease should have received, there is more controversy surrounding the creation and administration of lifesaving covid-19 vaccines than was ever expected. Whether a continuation of administrative disdain for the vaccine or push back based on actual health consequences, an age of precaution and hesitancy has been ushered in surrounding vaccine utilization. To better observe this concept, one must first understand the root of vaccine hesitancy, one avenue of which stems from the use of stem cells in the production and manufacturing of vaccines. Once familiar with the concept of stem cell use and vaccine production a closer look must be taken into specifically the use of stem cells in the current production of the covid-19 vaccine, given the huge backlash it has received in the public and media. From here, a broader explanation of anti-vaccination narratives was analyzed, concentrating on the three main defenses for these stances. Following this analysis, a comparative of the three common vaccines available on the market, Moderna, Pfizer, and Johnson & Johnson, including their performance in human trials and efficacy studies is discussed. This article focuses on identifying the foundation of vaccine science while offering a descriptive explanation of Covid-19 vaccination research completed.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131171324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Presenting as an Acute Myopericarditis: A Case Report Study COVID-19表现为急性心肌炎:一例报告研究
Journal of Virology Research &amp; Reports Pub Date : 2022-03-31 DOI: 10.47363/jvrr/2022(3)140
Ibrar Anjum
{"title":"COVID-19 Presenting as an Acute Myopericarditis: A Case Report Study","authors":"Ibrar Anjum","doi":"10.47363/jvrr/2022(3)140","DOIUrl":"https://doi.org/10.47363/jvrr/2022(3)140","url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is a global challenge for the health care community. It typically presents with fever, generalized fatigue, dyspnea and rarely with chest pain due to involvement of heart. We report a 26-year-old young man with no significant risk factor for coronary artery disease who presented with chest pain and elevated troponin due to myopericarditis. Cardiac ischemic work up was negative for acute coronary artery disease. However, his PCR came positive for SARS-CoV-2 pneumonia. To decrease morbidity and mortality in young adults, clinicians should be aware of atypical presentation of COVID-19 pneumonia to diagnose in an early stage and initiate prompt treatment management. Learning Points • Identify myopericarditis as an atypical presentation of COVID-19 • Early recognition and prompt treatment initiation can prevent cardiac complications and mortality","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"267 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121337993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Origin of the Sars‑Cov‑2 in the United States as a Biological Weapon Sars - Cov - 2在美国作为生物武器的起源
Journal of Virology Research &amp; Reports Pub Date : 2022-03-31 DOI: 10.47363/jvrr/2022(3)141
Joseph Angel de Soto
{"title":"The Origin of the Sars‑Cov‑2 in the United States as a Biological Weapon","authors":"Joseph Angel de Soto","doi":"10.47363/jvrr/2022(3)141","DOIUrl":"https://doi.org/10.47363/jvrr/2022(3)141","url":null,"abstract":"Introduction: The SARS-CoV-2 virus was first reported in Wuhan China in Dec 2019, since then 279 million have been infected and 5.4 million have died. This has raised the question where did the SARs-CoV-2 virus originate? Methodology: In this study, the literature was reviewed, and the scientific and intelligence evidence assessed. Interviews were made with scientists and victims involved in the creation of the virus in both the United States and China. Results: The evidence suggest that the SARs-CoV-2 virus began as bat virus which was then manipulated in the lab via gain of function research in the United States funded by the National Institutes of Health under Dr. Fauci. This proto-biological weapon was then given to the Chinese and passed through Uighur prisoners. It is hypothesized that the modest common Altaic ancestry between American Native Americans and the Uighur from North Central Asia may in part account for the increased death rates of Native Americans in the United States. Conclusion: The SARS- CoV-2 virus with near scientific certainty originated in the United States as a proto-biological weapon which was further clinically developed in China in a collaborative effort as a biological weapon to target ethnic and racial minorities by both China and the United States.","PeriodicalId":294197,"journal":{"name":"Journal of Virology Research &amp; Reports","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133980649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书